|
|
|
|
||
Re: Adam Feuerstein's question to Sarepta advocates in his 1/20/14 article re JPM controversy column<<When GSK walked (for nothing), the SRPT political pressure was already there. Why did they walk?>> The pressure has clearly just gotten more extreme. I.e. Ataluren was approved after GSK dropped. |
return to message board, top of board |